Showing posts with label PerkinElmer. Show all posts
Showing posts with label PerkinElmer. Show all posts

Monday, August 8, 2011

Fluor (FLR) (PKI) (DLB) (ARCC) (GNOM) (SD) Price Targets Changed

Fluor Co. (NYSE: FLR), PerkinElmer, Inc. (NYSE: PKI), Dolby Labs (NYSE: DLB), Ares Capital (NASDAQ: ARCC), Complete Genomics (NASDAQ: GNOM) and SandRidge Energy Inc. (NYSE: SD) price targets adjusted by analysts.

Fluor Co. (FLR) had its price target raised by Credit Suisse (NYSE:CS) to $86.00. They have an “Outperform” rating on the company.

PerkinElmer, Inc. (PKI) had its price target lowered by UBS AG (NYSE:UBS) from $31.00 to $28.00. They have a “Buy” rating on the company.

Dolby Labs (DLB) had its price target lowered by Canaccord Genuity from $54.00 to $33.00. They have a “Hold” rating on the company.

Ares Capital (ARCC) had its price target lowered by Citigroup (NYSE:C) to $17.00. They have a “Buy” rating on the company.

Complete Genomics (GNOM) had its price target lowered by UBS AG from $15.00 to $8.50. They have a “Neutral” rating on the company.

SandRidge Energy Inc. (SD) had its price target lowered by UBS AG to $10.00. They have a “Neutral” rating on the company.

Monday, May 9, 2011

Price Targets (NRG) (PEG) (PKI) (RBCN) (SLXP) Updated

Price Targets on NRG Energy, Inc. (NYSE: NRG), Public Service Enterprise Group Inc. (NYSE: PEG), PerkinElmer, Inc. (NYSE: PKI), Rubicon Technology, Inc. (NASDAQ: RBCN) and Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) were updated by analysts.

Barclays Capital raised their price target on NRG Energy, Inc. (NRG) from $19.00 to $22.00. They have an “equal weight” rating on the company.

Barclays Capital raised their price target on Public Service Enterprise Group Inc. (PEG) from $31.00 to $33.00. They have an “equal weight” rating on the company.

Deutsche Bank (NYSE:DB) raised their price target on PerkinElmer, Inc. (PKI) from $30.00 to $35.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on Rubicon Technology, Inc. (RBCN) from $38.00 to $40.00. They have a “buy” rating on the company.

UBS AG raised their price target on Salix Pharmaceuticals, Ltd. (SLXP) from $37.00 to $39.00. They have a “neutral” rating on the company.

Friday, May 6, 2011

Price Targets on (ORA) (ORN) (PCG) (PCLN) (PKI) Updated

Analysts updated their price targets on Ormat Technologies (NYSE: ORA), Orion Marine Group, Inc. (NYSE: ORN), PG&E Co. (NYSE: PCG), Priceline (NASDAQ: PCLN) and PerkinElmer, Inc. (NYSE: PKI) today.

Ardour Capital cut their price target on Ormat Technologies (ORA) from $27.00 to $24.00. They now have a “buy” rating on the company.

FBR Capital cut their price target on Orion Marine Group, Inc. (ORN) from $14.00 to $11.00. They have an “outperform” rating on the company.

FBR Capital cut their price target on PG&E Co. (PCG) from $51.50 to $48.00. They have an “outperform” rating on the company.

Caris & Company raised their price target on Priceline (PCLN) from $555.00 to $630.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on PerkinElmer, Inc. (PKI) to $31.00. They have a “buy” rating on the company.